ClinicalTrials.Veeva

Menu

T-DOC® NXT Clinical Investigation

Laborie Medical Technologies logo

Laborie Medical Technologies

Status

Completed

Conditions

Incontinence, Urge

Treatments

Device: TDOC NXT

Study type

Interventional

Funder types

Industry

Identifiers

NCT03615001
TDOC-NXT-01

Details and patient eligibility

About

Assessing the Performance, Safety and Usability of our Next Generation T-DOC® NXT Catheter for Performing Urodynamic Studies

Enrollment

20 patients

Sex

All

Ages

21+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and Female (Adult age 21+)
  • Patients with clinical indication for urodynamics (UDS) testing, for any medically necessary reason as per the physician.

Exclusion criteria

  • Patients who suffer from bladder infections (not including patients with asymptomatic bacteriuria)
  • Patients who are pregnant
  • Patients with recent (less than 2 weeks) pelvic floor surgery
  • Patients who require the use of a suprapubic catheter
  • Patients with significant cognitive deficiency that prevent the patient from giving informed consent

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Urodynamics Arm
Experimental group
Treatment:
Device: TDOC NXT

Trial documents
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems